Rubius names ex-GlaxoSmithKline VP as CMO as CAR-T rivals near clinic – FierceBiotech
FierceBiotech |
Rubius names ex-GlaxoSmithKline VP as CMO as CAR–T rivals near clinic
FierceBiotech Rubius Therapeutics has lured Chris Carpenter, M.D., Ph.D., away from GlaxoSmithKline to serve as its CMO. Carpenter will work as point person on Rubius' clinical development activities as it gears up to move the first of its CAR–T-rivaling cell … |
